$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"

논문 상세정보

Abstract

Objectives The principal aim of the present study was to investigate the characteristic depressive symptoms in patients with social anxiety disorder (SAD) and panic disorder in comparison to patients with depressive disorder. Methods This study included 132 patients with SAD, 128 panic disorder and 64 depressive disorder (major depressive disorder, dysthymia etc.) patients without comorbid psychiatric disorders. The Beck Depressive Inventory (BDI) is used to measure depressive symptoms. We divided BDI into three categories originally described by Shafer AB, including negative attitude toward self, performance impairment, and somatic symptoms. We compared the depressive symptoms of SAD, panic disorder and depressive disorder by using ANOVA. Results Negative attitude toward self was noticeable in SAD (SAD $0.54{\pm}0.23$, panic disorder $0.41{\pm}0.17$, depressive disorder $0.46{\pm}0.11$, p < 0.001). Performance impairment and somatic symptoms were remarkable in panic disorder than in SAD and depressive disorder (performance impairment : SAD $0.39{\pm}0.21$, panic disorder $0.44{\pm}0.14$, depressive disorder $0.40{\pm}0.09$, p = 0.009 ; somatic symptoms : SAD $0.07{\pm}0.10$, panic disorder $0.15{\pm}0.12$, depressive disorder $0.14{\pm}0.08$, p < 0.001). Conclusions The results facilitate an approach to optimal treatment for patients with comorbidity of anxiety disorder and depression.

질의응답 

키워드에 따른 질의응답 제공
핵심어 질문 논문에서 추출한 답변
사회불안장애
사회불안장애는 무엇인가?
한 가지 또는 그 이상의 사회적 상황이나 활동상황에 대한 현저하고 지속적인 두려움을 특징으로 하는 질환

불안장애 중 그 빈도가 높다고 알려진 사회불안장애는 한 가지 또는 그 이상의 사회적 상황이나 활동상황에 대한 현저하고 지속적인 두려움을 특징으로 하는 질환으로, 미국에서 시행된 National Comorbidity Survey에서 사회불안장애의 평생 유병률을 13.3%로 보고하였다.

공황장애
공황장애는 무엇인가?
갑자기 극심한 공황발작이 유발되고 이러한 공황발작이 다시 일어날 것에 대해 지속적으로 염려하는 예기불안을 특징으로 하는 질환

공황장애는 갑자기 극심한 공황발작이 유발되고 이러한 공황발작이 다시 일어날 것에 대해 지속적으로 염려하는 예기불안을 특징으로 하는 질환으로, 전체 인구에서 약 1~3%의 유병률을 보인다.5)16-18) 공황장애 환자 중 44~91%가 주요우울증을 동반하고 있다고 알려져 있으며, 우울증이 없는 공황 장애 환자들에 비해 우울증을 동반하고 있는 공황장애 환자들의 경우 증상이 더욱 심각하고, 주관적으로 느끼는 고통이나 회피 행동도 더욱 큰 것으로 보고되고 있다.

불안장애와 우울장애를 공존질환
불안장애와 우울장애를 공존질환을 갖는 환자들은 어떠한 특징을 가지는가?
알코올 또는 물질 남용이 흔하고, 높은 자살 위험성과 낮은 치료 반응률을 보이는 것

불안장애와 우울장애를 공존질환으로 갖는 환자들은 증상 정도가 심하며, 기능의 저하가 현저하다고 알려져 있다. 또한 이러한 경우에는 알코올 또는 물질 남용이 흔하고, 높은 자살 위험성과 낮은 치료 반응률을 보이는 것으로 보고되고 있다.1)

질의응답 정보가 도움이 되었나요?

참고문헌 (50)

  1. 1. Kaufman J, Charney D. Comorbidity of mood and anxiety disorders. Depress Anxiety 2000;12 Suppl 1:69-76. 
  2. 2. Aderka IM, Hofmann SG, Nickerson A, Hermesh H, Gilboa- Schechtman E, Marom S. Functional impairment in social anxiety disorder. J Anxiety Disord 2012;26:393-400. 
  3. 3. Stein MB, Kean YM. Disability and quality of life in social phobia: epidemiologic findings. Am J Psychiatry 2000;157:1606-1613. 
  4. 4. Schneier FR, Heckelman LR, Garfinkel R, Campeas R, Fallon BA, Gitow A, et al. Functional impairment in social phobia. J Clin Psychiatry 1994;55:322-331. 
  5. 5. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19. 
  6. 6. Brown TA, Barlow DH. Comorbidity among anxiety disorders: implications for treatment and DSM-IV. J Consult Clin Psychol 1992; 60:835-844. 
  7. 7. Davidson JR, Hughes DL, George LK, Blazer DG. The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. Psychol Med 1993;23:709-718. 
  8. 8. Gelernter CS, Uhde TW, Cimbolic P, Arnkoff DB, Vittone BJ, Tancer ME, et al. Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study. Arch Gen Psychiatry 1991;48:938-945. 
  9. 9. Lecrubier Y, Weiller E. Comorbidities in social phobia. Int Clin Psychopharmacol 1997;12 Suppl 6:S17-S21. 
  10. 10. Nelson EC, Grant JD, Bucholz KK, Glowinski A, Madden PAF, Reich W, et al. Social phobia in a population-based female adolescent twin sample: co-morbidity and associated suicide-related symptoms. Psychol Med 2000;30:797-804. 
  11. 11. Noyes R Jr, Moroz G, Davidson JR, Liebowitz MR, Davidson A, Siegel J, et al. Moclobemide in social phobia: a controlled dose-response trial. J Clin Psychopharmacol 1997;17:247-254. 
  12. 12. Schneier FR, Saoud JB, Campeas R, Fallon BA, Hollander E, Coplan J, et al. Buspirone in social phobia. J Clin Psychopharmacol 1993;13:251-256. 
  13. 13. Van Ameringen M, Mancini C, Styan G, Donison D. Relationship of social phobia with other psychiatric illness. J Affect Disord 1991;21:93-99. 
  14. 14. Ledley DR, Huppert JD, Foa EB, Davidson JR, Keefe FJ, Potts NL. Impact of depressive symptoms on the treatment of generalized social anxiety disorder. Depress Anxiety 2005;22:161-167. 
  15. 15. Erwin BA, Heimberg RG, Juster H, Mindlin M. Comorbid anxiety and mood disorders among persons with social anxiety disorder. Behav Res Ther 2002;40:19-35. 
  16. 16. Leon AC, Portera L, Weissman MM. The social costs of anxiety disorders. Br J Psychiatry Suppl 1995;(27):19-22. 
  17. 17. Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. Am J Psychiatry 2000;157:669-682. 
  18. 18. Katon WJ. Clinical practice. Panic disorder. N Engl J Med 2006;354:2360-2367. 
  19. 19. Clayton PJ. The comorbidity factor: establishing the primary diagnosis in patients with mixed symptoms of anxiety and depression. J Clin Psychiatry 1990;51 Suppl:35-39. 
  20. 20. Cassano GB, Perugi G, Musetti L, Akiskal HS. The nature of depression presenting concomitantly with panic disorder. Compr Psychiatry 1989;30:473-482. 
  21. 21. Charney DS, Heninger GR, Price LH, Breier A. Major depression and panic disorder: diagnostic and neurobiological relationships. Psychopharmacol Bull 1986;22:503-511. 
  22. 22. Reich JH. DSM-III personality disorders and the outcome of treated panic disorder. Am J Psychiatry 1988;145:1149-1152. 
  23. 23. Scheibe G, Albus M. Prospective follow-up study lasting 2 years in patients with panic disorder with and without depressive disorders. Eur Arch Psychiatry Clin Neurosci 1994;244:39-44. 
  24. 24. Vollrath M, Koch R, Angst J. The Zurich Study. IX. Panic disorder and sporadic panic: symptoms, diagnosis, prevalence, and overlap with depression. Eur Arch Psychiatry Neurol Sci 1990;239:221-230. 
  25. 25. Buller R, Maier W, Benkert O. Clinical subtypes in panic disorder: their descriptive and prospective validity. J Affect Disord 1986;11:105-114. 
  26. 26. Vollrath M, Angst J. Outcome of panic and depression in a sevenyear follow-up: results of the Zurich study. Acta Psychiatr Scand 1989;80:591-596. 
  27. 27. Hamilton M. The clinical distinction between anxiety and depression. Br J Clin Pharmacol 1983;15 Suppl 2:165S-169S. 
  28. 28. Lamers F, van Oppen P, Comijs HC, Smit JH, Spinhoven P, van Balkom AJ, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry 2011;72:341-348. 
  29. 29. Bittner A, Goodwin RD, Wittchen HU, Beesdo K, Hofler M, Lieb R. What characteristics of primary anxiety disorders predict subsequent major depressive disorder? J Clin Psychiatry 2004;65:618-626; quiz 730. 
  30. 30. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M. I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 Suppl 20:22-33; quiz 34-57. 
  31. 31. Yoo SW. Recent trends of anxiety disorders and the introduction of MINI. Jeju: GSK Satellite Symposium;2001. 
  32. 32. Yoo SW, Kim YS, Noh JS, Oh KS, Kim CH, Namkoong K, et al. Validity of Korean Version of the Mini-International Neuropsychiatric Interview. Anxiety and Mood 2006;2:50-55. 
  33. 33. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571. 
  34. 34. Han HM, Yeom TH, Shin YW, Kim KH, Yoon DJ, Jung KJ. A Standardization Study of Beck Depression Inventory in Korea. J Korean Neuropsychiatr Assoc 1986;25:487-500. 
  35. 35. Shafer AB. Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol 2006;62:123-146. 
  36. 36. Lee SH, Chung KS. A clinical study of social phobia(1). J Korean Neuropsychiatr Assoc 1984;23:111-116. 
  37. 37. Choi HM, Kim NH, Lim SW, Oh KS. Gender differences in the symptomatic characteristics of Social Phobia patients in one university hospital. Anxiety and Mood 2008;4:62-67. 
  38. 38. Wittchen HU, Stein MB, Kessler RC. Social fears and social phobia in a community sample of adolescents and young adults: prevalence, risk factors and co-morbidity. Psychol Med 1999;29:309-323. 
  39. 39. Weinstock LS. Gender differences in the presentation and management of social anxiety disorder. J Clin Psychiatry 1999;60 Suppl 9:9-13. 
  40. 40. Gokalp PG, Tukel R, Solmaz D, Demir T, Kiziltan E, Demir D, et al. Clinical features and co-morbidity of social phobics in Turkey. Eur Psychiatry 2001;16:115-121. 
  41. 41. Raguram R, Bhide AV. Patterns of phobic neurosis: a retrospective study. Br J Psychiatry 1985;147:557-560. 
  42. 42. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, et al. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 1997;54:305-309. 
  43. 43. Ehlers A, Margraf J, Roth WT. Selective information processing, interoception, and panic attacks. Panic and Phobias 1988;2:129-148. 
  44. 44. Simon NM, Otto MW, Korbly NB, Peters PM, Nicolaou DC, Pollack MH. Quality of life in social anxiety disorder compared with panic disorder and the general population. Psychiatr Serv 2002;53:714-718. 
  45. 45. Lee KM, Oh YH, Oh KS. Comparison of disabilities in patients with social phobia and panic disorder. J Korean Neuropsychiatr Assoc 2005;44:232-237. 
  46. 46. Green AC, Hunt C, Stain HJ. The delay between symptom onset and seeking professional treatment for anxiety and depressive disorders in a rural Australian sample. Soc Psychiatry Psychiatr Epidemiol 2012;47:1475-1487. 
  47. 47. Hollifield M, Katon W, Skipper B, Chapman T, Ballenger JC, Mannuzza S, et al. Panic disorder and quality of life: variables predictive of functional impairment. Am J Psychiatry 1997;154:766-772. 
  48. 48. Noyes R Jr, Reich JH, Suelzer M, Christiansen J. Personality traits associated with panic disorder: change associated with treatment. Compr Psychiatry 1991;32:283-294. 
  49. 49. Mavissakalian M, Hamann MS. DSM-III personality disorder in agoraphobia. II. Changes with treatment. Compr Psychiatry 1987;28:356-361. 
  50. 50. Green MA, Curtis GC. Personality disorders in panic patients: response to termination of antipanic medication. J personality Disorders 1988;2:303-314. 

문의하기 

궁금한 사항이나 기타 의견이 있으시면 남겨주세요.

Q&A 등록

원문보기

원문 PDF 다운로드

  • ScienceON :

원문 URL 링크

  • 대한생물정신의학회 : 저널
  • Korea Open Access Journals : 저널

원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다. (원문복사서비스 안내 바로 가기)

DOI 인용 스타일

"" 핵심어 질의응답